Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era

J Allergy Clin Immunol Pract. 2022 Jun;10(6):1434-1453.e9. doi: 10.1016/j.jaip.2022.03.002. Epub 2022 Mar 16.


Chronic rhinosinusitis (CRS) affects up to 12% of the general population and is traditionally divided into two main phenotypic subsets, based on the presence of nasal polyps (CRSwNP) or their absence. It is well-established that many patients with CRSwNP report poor quality of life (QoL), which is further compromised by comorbidities (eg, asthma, bronchiectasis, aspirin-exacerbated respiratory disease). Chronic rhinosinusitis CRS with nasal polyps is managed with a combination of medical therapy and surgical interventions, and biologics are emerging as a promising new treatment option for patients with inadequate response to the standard of care. A range of patient-reported outcome measures have been used to assess QoL for patients with CRSwNP in clinical trials, including disease-specific questionnaires (eg, Sino-Nasal Outcome Test-22) and generic ones (eg, Short Form-36). Significantly impaired QoL has been identified as a criterion for the indication to use biologics in patients with CRSwNP. This review summarizes clinical evidence (2010-2021) on QoL outcomes with currently available treatments for CRSwNP and assesses the improvement in QoL after biologic treatments, especially for patients with comorbidities reported in interventional studies (randomized controlled trials and real-world experience).

Keywords: Aspirin-exacerbated respiratory disease; Asthma; Loss of smell; Nasal polyposis; Nonsteroidal anti-inflammatory drug–exacerbated respiratory disease; Patient-reported outcomes.

Publication types

  • Review

MeSH terms

  • Biological Products* / therapeutic use
  • Chronic Disease
  • Humans
  • Nasal Polyps* / drug therapy
  • Nasal Polyps* / epidemiology
  • Quality of Life
  • Rhinitis* / drug therapy
  • Rhinitis* / epidemiology
  • Sinusitis* / drug therapy
  • Sinusitis* / epidemiology


  • Biological Products